| Mr Ryan Conlon Bushey, RPH | |
|
456 S Barre Rd, Barre, VT 05641-8107 | |
| (802) 479-0432 | |
| (802) 479-3326 |
| Full Name | Mr Ryan Conlon Bushey |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 456 S Barre Rd, Barre, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104149913 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 054238-1 (New York) | Primary |
| 183500000X | Pharmacist | 033.0047423 (Vermont) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Ryan Conlon Bushey, RPH 230 Brennan Woods Dr, Williston, VT 05495-8902 Ph: (802) 734-8319 | Mr Ryan Conlon Bushey, RPH 456 S Barre Rd, Barre, VT 05641-8107 Ph: (802) 479-0432 |
News Archive
Women exposed to high levels of fine particulate matter specifically during pregnancy-particularly during the third trimester-may face up to twice the risk of having a child with autism than mothers living in areas with low particulate matter, according to a new study from Harvard School of Public Health.
The U-Vip (Unit for Visually Impaired People) research team led by Monica Gori at the IIT- Istituto Italiano di Tecnologia has recently published a study which shows for the first time how children aged from 3 to 5 years old have problems in recognizing the emotions of people wearing surgical masks.
The FDA recently approved the immunotherapy drug pembrolizumab as a first-line treatment for patients with certain types of advanced colorectal cancer. This is the 9th FDA approval supported by Stand Up To Cancer® (SU2C) research.
Tianyin Pharmaceutical Inc., a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (TCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the first quarter of Fiscal Year 2012.
The Financial Times reports on a legal dispute between the Indian government and the German pharmaceutical group Bayer, writing, "Bayer is appealing against the Indian patent controller's decision in March to override the company's monopoly on its cancer drug Nexavar, and to allow an Indian company to produce and sell the life-extending drug for just $173 a month - one-sixth of the $5,500 a month price charged by Bayer."
› Verified 4 days ago
Christina Barr, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 298 Partridge Rd, Barre, VT 05641 Phone: 802-881-4011 | |
Mrs. Heidi M Yialiades, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 456 S Barre Rd, Barre, VT 05641 Phone: 802-479-0432 Fax: 802-479-2367 | |
Tracey Rossi, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Us Route 302, Barre, VT 05641 Phone: 802-476-6659 Fax: 802-479-5989 | |
Kristen Marjorie Poulin, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Us Route 302, Barre, VT 05641 Phone: 802-476-6659 Fax: 802-479-5989 | |
Ellen Barton, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Us Route 302, Barre, VT 05641 Phone: 802-476-6659 | |
Carrie Ann Chew, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 355 N Main St, Barre, VT 05641 Phone: 802-476-4311 |